Company intelligence / Profile preview

XTuit Pharmaceuticals

Waltham, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

XTuit developed small molecule and polymer-drug conjugate therapies to alleviate tumor hypoxia, enhance drug uptake, and reduce drug resistance by targeting the tumor microenvironment; compounds modulate extracellular matrix and stromal cell activation, with clinical objectives in cancer and fibrosis

Therapeutic areas: GastroenterologyOncology
Modalities: Small moleculePolymer-drug conjugate therapy (Polyacetal polymer-based conjugates)
Industry: Biotech

Beyond the preview

Go deeper on XTuit Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XTuit Pharmaceuticals.

Explore the full profile